Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen

References

• CottrellMLKashubaADTopical microbicides and HIV prevention in the female genital tractJ Clin Pharmacol201454660361524664786
   PubMedGoogle Scholar
• GrantRMHamerDHopeTWhither or wither microbicides?Science2008321588853253418653884
   PubMed Web of Science ®Google Scholar
• VanpouilleCArakelyanAMargolisLMicrobicides: still a long road to successTrends Microbiol201220836937522705107
   PubMed Web of Science ®Google Scholar
• FichorovaRNTuckerLDAndersonDJThe molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmissionJ Infect Dis2001184441842811471099
   PubMedGoogle Scholar
• McCormackSRamjeeGKamaliAPRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialLancet201037697491329133720851460
   PubMed Web of Science ®Google Scholar
• ZirafiOKimKARoanNRSemen enhances HIV infectivity and impairs the antiviral efficacy of microbicidesSci Transl Med20146262262ra157
   PubMed Web of Science ®Google Scholar
• BernsteinDIStanberryLRSacksSEvaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpesAntimicrob Agents Chemother200347123784378814638483
   PubMedGoogle Scholar
• PriceCFTyssenDSonzaSSPL7013 Gel (VivaGel(R)) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humansPLoS One201169e2409521935377
   PubMed Web of Science ®Google Scholar
• Abdool KarimSSRichardsonBARamjeeGSafety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenAIDS201125795796621330907
   PubMed Web of Science ®Google Scholar
• HuskensDVermeireKProfyATScholsDThe candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1Antiviral Res2009841384719664662
   PubMed Web of Science ®Google Scholar
• MohanPScholsDBabaMDe ClercqESulfonic acid polymers as a new class of human immunodeficiency virus inhibitorsAntiviral Res19921821391501384428
   PubMedGoogle Scholar
• RusconiSMoonisMMerrillDPNaphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activitiesAntimicrob Agents Chemother19964012342368787913
   PubMed Web of Science ®Google Scholar
• Scordi-BelloIAMosoianAHeCCandidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of actionAntimicrob Agents Chemother20054993607361516127029
   PubMed Web of Science ®Google Scholar
• Van DammeLGovindenRMirembeFMLack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmissionN Engl J Med2008359546347218669425
   PubMed Web of Science ®Google Scholar
• García-MerinoIde Las CuevasNJiménezJLThe Spanish HIV BioBank: a model of cooperative HIV researchRetrovirology200962719272145
   PubMed Web of Science ®Google Scholar
• RasinesBSánchez-NievesJMaioloMSynthesis, structure and molecular modelling of anionic carbosilane dendrimersDalton Trans20124141127331274822968584
   PubMed Web of Science ®Google Scholar
• Vacas CórdobaEArnaizERellosoMDevelopment of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmissionAIDS20132781219122923925376
   PubMedGoogle Scholar
• ChouTCTalalayPQuantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdv Enzyme Regul19842227556382953
   PubMedGoogle Scholar
• ChoncoLPionMVacasECarbosilane dendrimer nanotechnology outlines of the broad HIV blocker profileJ Control Release2012161394995822652549
   PubMed Web of Science ®Google Scholar
• Sánchez-RodríguezJVacas-CórdobaEGómezRDe La MataFJMuñoz-FernándezMANanotech-derived topical microbicides for HIV prevention: the road to clinical developmentAntiviral Res2015113334825446339
   PubMedGoogle Scholar
• TelwatteSMooreKJohnsonAVirucidal activity of the den-drimer microbicide SPL7013 against HIV-1Antiviral Res201190319519921459115
   PubMedGoogle Scholar
• MoscickiABKaulRMaYMeasurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safetyJ Acquir Immune Defic Syndr201259213414022067666
   PubMed Web of Science ®Google Scholar
• ArnoldFSchnellJZirafiONaturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloido-genic enhancers of HIV infectionJ Virol20128621244124922090109
   PubMed Web of Science ®Google Scholar
• NeurathARStrickNLiYYRole of seminal plasma in the anti-HIV-1 activity of candidate microbicidesBMC Infect Dis2006615017042959
   PubMedGoogle Scholar
• RoanNRMullerJALiuHPeptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infectionCell Host Microbe201110654155022177559
   PubMedGoogle Scholar
• UsmaniSMZirafiOMüllerJADirect visualization of HIV-enhancing endogenous amyloid fibrils in human semenNat Commun20145350824691351
   PubMed Web of Science ®Google Scholar
• TanQZhuYLiJStructure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complexScience201334161521387139024030490
   PubMed Web of Science ®Google Scholar
• Sepúlveda-CrespoDGómezRDe La MataFJJimenezJLMunoz-FernandezMAPolyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapyNanomedicine20151161481149825835558
   PubMedGoogle Scholar
• Sepúlveda-CrespoDSerramíaMJTagerAMPrevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16Nanomedicine20151161299130825959924
   PubMedGoogle Scholar
• Lackman-SmithCOsterlingCLuckenbaughKDevelopment of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicidesAntimicrob Agents Chemother20085251768178118316528
   PubMedGoogle Scholar
• TanSLuLLiLPolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionPLoS One201383e5977723544097
   PubMed Web of Science ®Google Scholar
• KellerMJMesquitaPMTorresNMPostcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsPLoS One201051e878120107502
   PubMed Web of Science ®Google Scholar
• HeroldBCMesquitaPMMadanRPKellerMJFemale genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infectionsAm J Reprod Immunol201165332533321143689
   PubMedGoogle Scholar
• PatelSHazratiECheshenkoNSeminal plasma reduces the effectiveness of topical polyanionic microbicidesJ Infect Dis200719691394140217922405
   PubMedGoogle Scholar